Shunji Haruta,Nikhilesh N. Singh,John Kollins,Salvador Rico
申请号：
US16414350
公开号：
US20190275036A1
申请日:
2019.05.16
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Presented herein are powder formulations comprising dihydroergotamine (DHE), or a pharmaceutically acceptable salt thereof. In addition to such formulations, also presented herein are methods comprising intranasally administering powder formulations comprising dihydroergotamine, or a pharmaceutically acceptable salt thereof. The presented methods can be used for treating headache, for example, for rapid onset treatment of headache, including migraine, e.g. acute treatment of migraine with or without aura.
